Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Nov-Dec;34(7):749-57.
doi: 10.3747/pdi.2013.00305. Epub 2014 Oct 7.

Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system

Frank X Liu  1 , Surrey M Walton  1 , Robert Leipold  1 , Deborah Isbell  1 , Thomas A Golper  1
Affiliations
Comparative Study

Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system

Frank X Liu et al. Perit Dial Int. 2014 Nov-Dec.

Abstract

Background: The economic burden of treating end-stage renal disease (ESRD) continues to grow. As one response, effective January 1, 2011, Medicare implemented a bundled prospective payment system (PPS, including injectable drugs) for dialysis patients. This study investigated the 5-year budget impact on Medicare under the new PPS of changes in the distribution of patients undergoing peritoneal dialysis (PD), in-center hemodialysis (ICHD), and home hemodialysis (HHD).

Methods: An Excel-based budget impact model was created to assess dialysis-associated Medicare costs. The model accounted for dialysis access establishment, the current monthly capitation physician payment for ESRD, Medicare dialysis payments (including start-up costs), training, oral drug costs, and the costs and probabilities of adverse events including access failure, hospitalization for access infection, pneumonia, septicemia, and cardiovascular events. United States Renal Data System (USRDS) data were used to project the US Medicare dialysis patient population across time. The baseline scenario assumed a stable distribution of PD (7.7%), HHD (1.3%) and ICHD (91.0%) over 5 years. Three comparison scenarios raised the proportions of PD and HHD by (1) 1% and 0.5%, (2) 2% and 0.75%, and (3) 3% and 1% each year; a fourth scenario held HHD constant and lowered PD by 1% per year.

Results: Under the bundled PPS, scenarios that increased PD and HHD from 7.7% and 1.3% over 5 years resulted in cumulative savings to Medicare of $114.8M (Scenario 1, 11.7% PD and 3.3% HHD at year 5), $232.9M (Scenario 2, 15.7% PD and 4.3% HHD at year 5), and $350.9M (Scenario 3, 19.7% PD and 5.3% HHD at year 5). When the PD population was decreased from 7.7% in 2013 to 3.7% by 2017 with a constant HHD population, the total Medicare payment for dialysis patients increased by over $121.2M.

Conclusions: Under Medicare bundled PPS, increasing the proportion of patients on PD and HHD vs ICHD could generate substantial savings in dialysis-associated costs to Medicare.

Keywords: End-stage renal disease; Medicare; bundled payment; dialysis; economics; financial impact analysis; prospective payment system.

PubMed Disclaimer

References

    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298(17):2038–47. - PubMed
    1. Chan KE, Pflederer TA, Steele DJ, Lilly MP, Ikizler TA, Maddux FW, et al. Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty. Clin J Am Soc Nephrol 2011. November; 6(11):2669–80. - PMC - PubMed
    1. Fresenius Medical Care. ESRD Patients in 2011: A Global Perspective. 2012.
    1. United States, Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System (USRDS). USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: USRDS; 2013.
    1. National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance-No 48: Guidance on Home Compared with Hospital Haemodialysis for Patients with End-Stage Renal Failure. London, UK: National Institute for Clinical Excellence; 2002.

Publication types

LinkOut - more resources